These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11769821)

  • 21. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
    de Sola S; Tarancón T; Peña-Casanova J; Espadaler JM; Langohr K; Poudevida S; Farré M; Verdejo-García A; de la Torre R
    Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive performance amongst recreational users of "ecstasy".
    Rodgers J
    Psychopharmacology (Berl); 2000 Jul; 151(1):19-24. PubMed ID: 10958112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP; Rogers RD; Sahakian BJ
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA; Wetherell MA; Fisk JE; Montgomery C
    Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Nulsen C; Fox A; Hammond G
    Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J; Buchanan T; Scholey AB; Heffernan TM; Ling J; Parrott AC
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC; Sisk E; Turner JJ
    Drug Alcohol Depend; 2000 Jul; 60(1):105-10. PubMed ID: 10821995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.